These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24666739)

  • 21. Simplifying QT prolongation for busy clinicians.
    Grindrod KA; Nagge J
    Can Fam Physician; 2019 Apr; 65(4):268-270. PubMed ID: 30979760
    [No Abstract]   [Full Text] [Related]  

  • 22. What has the patient been taking?
    Pasco J
    Aust Fam Physician; 1998 Jun; 27(6):517. PubMed ID: 9648320
    [No Abstract]   [Full Text] [Related]  

  • 23. The perfect storm: Torsades de Pointes in a child with leukemia.
    Bagatell R; Hainstock M; Lowe MC; Barber BJ; Samson RA
    Pediatr Blood Cancer; 2007 Dec; 49(7):996-9. PubMed ID: 16333840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adverse drug reactions--case report].
    Haffner S; Lapp H; Thürmann PA
    Dtsch Med Wochenschr; 2002 May; 127(19):1021. PubMed ID: 11997869
    [No Abstract]   [Full Text] [Related]  

  • 25. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.
    Justo D
    Arch Intern Med; 2006 Nov; 166(20):2288; author reply 2289-90. PubMed ID: 17101953
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clarithromycin-induced torsades de pointes].
    Yamaguchi S; Kaneko Y; Yamagishi T; Ohyama Y; Amano M; Arai M; Nakamura T; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2003 Jan; 92(1):143-5. PubMed ID: 12652715
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long QT-syndrome as a drug-induced side effect].
    Pohjola-Sintonen S
    Duodecim; 1998; 114(19):1891, 1893, 1895. PubMed ID: 11717743
    [No Abstract]   [Full Text] [Related]  

  • 28. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long QT interval as adverse effect--risk of fatal arrhythmias].
    Bathen J; Spigset O
    Tidsskr Nor Laegeforen; 2000 Nov; 120(28):3432-4. PubMed ID: 11187201
    [No Abstract]   [Full Text] [Related]  

  • 37. Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors.
    Bertino JS; Owens RC; Carnes TD; Iannini PB
    Clin Infect Dis; 2002 Mar; 34(6):861-3. PubMed ID: 11830802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening drugs for QT prolongation.
    Somberg J
    Am J Ther; 2007; 14(5):419-20. PubMed ID: 17890927
    [No Abstract]   [Full Text] [Related]  

  • 39. Takotsubo cardiomyopathy and torsade de pointes in myasthenic crisis: be aware of QT prolongation.
    Valbusa A; Ingrassia S; Rosa GM; Infante MT; Schenone A; Montecucco F; Cordano C
    Am J Emerg Med; 2013 Dec; 31(12):1717-8. PubMed ID: 24161204
    [No Abstract]   [Full Text] [Related]  

  • 40. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.